Topic Archives: Dr. KSS

Tear Sheet: CohBar Inc. ($CWBR)

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for our Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]

Oncotutorial

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]

Long Idea of the Year

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his old articles and his most recent comments on his Stock Gumshoe page.] “Keep it quiet. (Go slow.) […]

Quickster: Update on Corbus

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. To see all of his column and his latest comments, go to his Stock Gumshoe page.] [Author’s note: This commentary has been […]

Such A Pleasant Stay

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Thanks to you I’m much obliged Such a […]

Sea of Tranquility

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “I live in the light of the bright summer […]

Tropic of Palatin

[Ed. Note: Dr. KSS writes about biotech and medicine for the Irregulars. He has agreed to our trading restrictions, chooses his own topics and his thoughts and opinions are his own. His previous columns and recent comments can be found on his Stock Gumshoe page.] “He had never seen her body so abandoned, so unconscious […]

Ten Common Biotech Investing Mistakes

[Ed. Note: Dr. KSS writes about medicine biotech stocks for the Gumshoe Irregulars. He chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page for his past articles and most recent comments.] Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But the task […]

Quickster: T2 Biosystems ($TTOO)

[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page to see his biography, latest comments and past articles.] About 18 months ago, I came across tiny Boston-area diagnostics start-up […]

Conflict Diamonds

[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trade restrictions, chooses his own topics, and his words and opinions are his own. You can see all his past articles and more recent comments here.] Picture the gurbling fumaroles of Yellowstone: from the late 1990’s and on into […]

What Pliny Said

Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions and his words and opinions are his own. You can see his biography and past articles here. In the beginning, there was a canopy, verdant and succulent, given to inky-black nights punctuated by the utterances […]

Cyto Who?

[Ed. Note: Dr. KSS is an MD and PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and recent comments here.] You’re probably getting it right by now—writing “2016” and not “2015.” […]

The Sophiris Boondoggle

A brief column, if I may, to capture the teachable moment offered to us by the release of 52-week data from Sophiris ($SPHS). Longer-term readers recall that we first introduced Sophiris as a long investment idea on 30 November 2014. The company had taken an unusual toxin, called aerolysin, from the freshwater bacteria Aeromonas that, when activated, […]

The Manchurian Candida

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and biography here.] “Many things you hear in this room are untrue.” (sign posted in Yale-New Haven Medical Center physician cafeteria) […]

Is Zafgen Kaput?

“It was like a teetering house of cards, A contortionist strumming a ukulele, A gorilla raging in someone’s attic, A car graveyard frantic to get back On the interstate highway in a tornado, Tolstoy’s beard in his mad old age, General Custer’s stuffed horse… What was? I ask myself and have no idea, But it’ll […]

The Postman Always Rings Nice

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can read his past articles, latest comments, and bio here.] We love when readers write in, and most of the questions, even though privately put, are […]

The Tao of Recro

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his past articles here.] “Who wants honey? As long as there’s some money?” —–“Cherub Rock,” Smashing Pumpkins, Siamese Dream (words and […]

CellCeutix: 23 Minutes with Leo Ehrlich

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his past articles here.] “All non-denial denials. They doubt our ancestry, but they don’t say the story isn’t accurate.” —-from All the President’s […]

The Second Coming of TransEnterix?

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his previous articles and most recent comments here.] Go on, admit it: you enjoyed that rambunctious little scene in Ridley Scott’s Prometheus […]

Cisco, Chang & Charlie, Part Two

[Dr. KSS writes about medicine and biotech stocks for the Irregulars. You can find his biography and previous columns here. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] Second of Three Parts Frederick Towne Melges, M.D. The name probably doesn’t stir the memory banks of Gumshoe readers. […]

Cisco, Chang & Charlie

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his past articles here. Enjoy!] Do you have quirky, enigmatic notions that hang with you? Douglas Hofstadter, writing in Godel, Escher and Bach: […]

Special Bulletin: The CoLucid IPO

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. You can see all of his articles archived here. Enjoy!] CoLucid Pharmaceuticals, which recently moved from Durham, NC, to Cambridge, MA, plans an initial public offering. Recent news suggests the […]

The Last Samurai Biotech

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. His bio, past articles, and most recent comments can be seen here. Enjoy!] OUT of the night that covers me, Black as the Pit from pole to pole, I thank […]

Primer on Drug Development

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, and his words and opinions are his own. This piece is for reference. You can see all of his articles here.] For biotech Irregulars, this is a concise overview of what goes on in each phase […]

Gumshoe BioDimSum II: Corralling the “A” Biotechs Plus a New Long Selection

[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]

The Zed Files

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] It could be the premise of a tawdry unrated movie that teenage boys sneak glimpses of on Netflix when they’re home alone. […]

Saving Jack Kerouac

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] His tidily rhyming names perhaps destined him for fame. While Jack Kerouac’s work and popularity were before my time, his cultural and literary restlessness assure him […]

Big Bucks from Big Prostates?

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] Readers not familiar with Stock Gumshoe usually arrive wondering if the salivation provoked by stock promotional writers for certain companies is justified. […]

A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right?

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]

Why Regado May be Oversold

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading rules and he chooses his own topics. His words and opinions are his own. Enjoy!] In June 1962, women working in the dressmaking arm of a certain American textile factory were overcome with fear. Rumors began […]

Comments

  • Avatar

    Claude Please note that Dr KSS has left this building. He no longer reads or posts here. You responded to a note that...

  • Avatar

    beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSSbeat Dr KSS sugar diet topic as...

  • Avatar

    beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSSbeat Dr KSS sugar diet topic as...

  • Avatar

    beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSS...

  • Avatar
  • Avatar
  • Avatar

    $AFMD NP tanglewood - Thanks for saying when Dr KSS mentioned it as I had no recollection at all of the stock....

  • Avatar

    More on $AFMD. Dr KSS first mentioned it in 'The Rest of the 12 Biotechs of Christmas' published on Feb 9,2017. At the ...

  • Avatar

    Thank you Ben for that info. I am still long this stock when Dr KSS first recommended it. Cost basis $2.26 per share on ...

  • Avatar

    $AUPH - Actually, in my experience, Helen can be terrific on holding hands. And so I'm clear: I did not, and would not, ...

  • Avatar

    $AUPH - etc. Keep in mind Helen uses technicals as well as science. One reason I chose not to follow Dr. KSS also applie...

  • Avatar

    Dear Dr KSS -- Thanks very much for this insightful review of cancer and its treatment in mainstream medicine. Your com...

  • Avatar

    Thanks for sharing, Jerome. I inquired awhile back if anyone out there smarter than I (that really opens it up) had any ...

  • LongOnLife

    STM, I couldn't agree more. I think KSS did have great insight into the science that he shared freely (early on at least...

  • Avatar

    $ARTH New Theme: "Dr. KSS program to make Stock Gumshoe great again: Arbitrarily kick people out of Biopubkss" ...

  • Avatar

    $ARTH $CWBR STM To be honest I hope we can just be on one thread. Gets too confusing. Dr. Norchi is the most car...

  • Avatar

    #Cleveland Apology Glad you brought it up. I was thinking about it. I do apologize to you and Hippockets and all. I w...

  • Avatar

    Off topic a bit (though it is related to small biocaps), but do you Travis, or anyone else know what became of the Newsl...

  • Avatar

    Oh Oh; it looks like the cat is out of the bag! So sarah you are the famous Alan Harris from Dr. KSS biotech thread....

  • Travis Johnson, Stock Gumshoe

    1. I don’t think that the SPLC is in any way a “terrorist organization.” 2. Lifetime memberships are non-refun...

  • LongOnLife

    $AKAO I think you hit the nail on the head STM. It would not surprise me if the FDA votes for approval for the BSI indic...

  • Avatar

    Plus...no Dr Kss for guidance on the medicine. I would not have gone into the sector at all without someone like him e...

  • Avatar

    The majority of money I have lost in the stock market has been due to following the advice of Dr. KSS so I for one will ...

  • Avatar

    $AUPH And then there was one..... As Dr. KSS predicted before he left, ImmuPharma's Lupuzor P3 for the treatment of Sy...

  • Avatar

    Why pray tell would anyone TD any of Ben's posts? What agenda would anyone have, sycophant or not, to derive pleasure ...

  • JohnM

    $CWBR, Are you saying that DR KSS and Cleveland have sold their shares?...

  • Avatar

    ptn $1.36 DR.KSS said he was still holding.That was about a year ago....

  • Avatar

    The new conference call with Dr KSS will be Friday 4/6 @ 12:30ET. Usual protocol - (712)770-4063 then 850326#. Callers w...

  • Avatar

    $Dr KSS Looks like I subscribed in time yesterday. Did it via PayPal to my bank acct. Sorry I broke the system. :(...

  • Avatar

    $DR. KSS $DR. Relentless THE NEW DR. KSS WEBSITE IS UP AND RUNNING!!! biopubkss.com...

  • Avatar

    SG Newsletters - FWIW - Many years ago, when I was grasping for valid information about biotech, and was a GS newbie, I ...

  • Avatar

    Frankly, Cleveland, if you will remember how hostile you were towards me, you might realize why I felt I could not have ...

  • Avatar

    Cleveland - I may be in the minority, which bothers me not at all, and I sincerely appreciate your comment(s). I've bee...

  • Avatar

    Does dr kss have a column or is the only access through twitter?...

  • Avatar

    I sold out when the market opened. Later I saw that Dr. KSS sold as well....

  • Avatar

    For those of you who were unable to participate in the conference call today with Dr. KSS and Processa Pharma, here is t...

  • Avatar

    # Conference Call Date Jim - I was simply replying to your post which stated, "A new conference call with Dr. KSS will ...

  • Avatar

    $APTO, ow - has been doing its own version of March Madness with CEO Rice (accompanied by CFO Chow) making presentations...

  • Avatar

    A new conference call with Dr. KSS will take place this Friday (10/23) at 12:30pm ET. The primary purpose is to showcase...

  • Avatar

    I'm out of $PTI. Dr. KSS spoke favorably of Julia S-S. Left with a modest profit....

  • Avatar

    $SNDX also out with nice profit! Thanks Dr KSS!...

  • Avatar

    $SRNE $VTGN - According to my notes, Dr. KSS said Sorrento went through a tumultuous time, but he thinks "they're go...

  • Avatar

    $RTTR For those who think institutions don't buy penny stocks....baker bros are long this one under 0.30 cents. Dr Kss ...

  • Avatar

    $SRNE np - Dr KSS on the call yesterday said 'to be cautious' with SRNE. He talked a bit about why, but I did not write...

  • Avatar

    Where do we find the List of the 12 Dr KSS stocks ?...

  • Avatar

    many thanks, Jim and Dr Kss....

  • Avatar

    $Ø Thanks for doing this Jim. As I'm not an active Twitter poster I hope someone will relay my thanks to Dr KSS for...

  • Avatar

    Comments copied from the biotech-discussion-continued thread on 3/8/18: vmsk33094 JoeS you wrote on 3/7/2018 that A...

  • Avatar

    $Conference Call 9.3.18 No this is a call which Dr KSS has referred to on Twitter. It looks as though he will be conduc...

  • Avatar

    $APTO Joe, Dr KSS said on 23.01.18 - "I predict that (lifting of clinical hold) will come during the 3rd week of Mar...

  • Avatar

    Here’s several comments about $APTO that were posted to the biotech-discussion-continued thread. ==================...

  • Avatar

    From https://www.stockgumshoe.com/2018/02/microblog-discussion-page-for-aurinia-pharmaceuticals-auph/ (a dedicated thre...

  • Avatar

    The $AUPH tab on the spreadsheet at http://tinyurl.com/KSSDAMAN has been updated with the latest comments from Dr. KSS....

  • Avatar

    $APTO long. This must be a significant milestone for Aptose. Dr. Rice and Greg Chow are presenting at 4 investor confe...

  • JohnM

    $Conference call with DR KSS Friday, March 9, at 12:30pm ET. To participate: Dial (712) 770-4063, and when prompted inpu...

  • Michael Jorrin,

    I (Doc Gumshoe) am staying with Stock Gumshoe - who bailed was Dr KSS. I wish him good fortune. I'll be on this webs...

  • DBMD

    $FATE ow taxable, this company is so diverse and grown so quick I forgot why I was in it. Also $ARTH ow taxable, green, ...

  • Avatar

    Travis, you might be too young to remember Paul Harvey, an ABC radio personality in the late 1900s. He was famous for...

  • Avatar

    #CURT Thanks. I am no saint or qualified for President. I just happen to have met the person #DRKSS. Since 2015 I w...

  • Avatar

    $ARTH ow and biggest holding: Hi Cleveland, still glad you are here brother! This is my first post in a while as I h...

  • Avatar

    Would someone provide the Dr KSS conference call replay number. I missed the call and the announcement....

  • Avatar

    Cleveland - Do you know whether DR KSS is working on a new (service) site?...

  • Avatar

    Cleveland - I really miss your commentary. I've been a huge fan since you saved my tail w/$CLRBZ. I deeply regret ANY ...

  • Avatar

    Pgathua, Glad to tell you everything I know (which I'm afraid isn't much) but I'm not business oriented enough to do mea...

  • Avatar

    In Feb. of 2016, Dr. KSS indicated a lack of enthusiasm for $EDIT....

  • Avatar

    Both Dr KSS and Helen have recommended $DMCAF on Twitter; also Oncolytics....

  • Avatar

    $DMCAF - np (sadly) - Looks like the jump coincides with the Dr KSS tweet that he quadrupled his position in it. I wa...

  • Avatar

    If you missed the S&P run because of investing in biotech, you should really do yourself a favor and learn to diversify ...

  • Avatar

    porgie - I don't think many here followed Dr. KSS like sheep. With that said, his background is none of my business; I ...

  • Avatar

    Ben, Roger, STM, et al - I have been following two stocks for personal reasons as well as investments - $AVXS and $RGNX....

  • Avatar

    Anyone else here invested in $CORT or have an opinion on this company? Lately I've been reading the following blog - ht...

  • Avatar

    Hi Porgie. I owned $SNDX for a while as well but sold out once I took another look at the phase 2 data for E2112 - HR+, ...

  • LongOnLife

    There are plenty of intelligent people who post here. If you don't know who they are and aren't willing to read anything...

  • LongOnLife

    It's too bad, too. All these folks were very bright and added a lot to the discussion. Hard to believe they all had such...

  • Avatar

    Had a great day. Thank you Dr. KSS and Helen....

  • Avatar

    And he posted his hateful vile on the internet to gain emotional revenge on the good Doc. You forgot that part. Just pla...

  • Avatar

    $CYDY np - this is why it would be so nice if Dr. KSS were still with us. The release above sounds and reads like good ...

  • Avatar

    $Dr.KSS stock recommendations I have been following some of this and other recent biotech thread’s discussions on the ...

  • Avatar

    Does anyone know the twitter address for Dr KSS? Thanks in advance!!...

  • JohnM

    $CAPR np, DR KSS latest tweet: "They got the regenerative medicine nod from FDA they'd been seeking. I had honestly pred...

  • Avatar

    STM thanks for the update. From the stocks from your portfolio i have an observation and potential income earner. $CLRB...

  • Avatar

    Even knowing what I know now...I would still invest with Dr KSS but that information would have been nice to know. Blata...

  • Avatar

    Cleveland - I miss you, Doc, LinLing, et al. Those posting negatives about Dr. KSS, in my opinion, are shown to be cow...

  • Avatar

    The true facts are that Dr Kss is very knowledgeable and saved all of us from lots of pitfalls but he also harmed a lot ...

  • Avatar

    Mary...can I list all the neuro plays Dr Kss stubbornly advanced here ..even after being questioned a few times. $CUR be...

  • JohnM

    mzimmer wrote: "Same with $TTPH. It was supposed to have doubled. Just bombed today." DR KSS on $TTPH: "Don't be a su...

  • Avatar

    Cleveland - I am trying to negotiate Twitter and would like to follow you if you are on there - I found Helen and I thin...

  • Avatar

    Dr KSS is the best source on the science behind bios that I've come across. My big regret is only finding him a year or ...

  • Avatar

    We live in an age where people on the board of local public school systems routinely receive death threats. DR KSS may n...

  • Avatar

    Totally !! Shameful !! Richardo: "Regardless of what you think or have read about Dr. KSS, for someone to denigrat...

  • Avatar

    cleveland- any update on when/if Dr KSS will have a new site available? I suppose you could contact me through Travis if...

  • Avatar

    Why 3 thumbs down for Cleveland (well now it is only 2) Cleveland is an honorable,man who has worked his a** off for us...

  • Avatar

    #Pure Hypocrisy Trash Dr. KSS viciously trying to harm him emotionally and then you pitch one of his picks????? Path...

  • Avatar

    $apto ow Not sure if there's anyone left here who can weigh in. There was a discussion on twitter, someone posed a quest...

  • Avatar

    $APTO ow I'm goin' on Dr. KSS' recommendation on this one and looking for some catalysts in the upcoming months. As fa...

  • Avatar

    The reaction of Dr.Kss is good enough for me !!!...

  • Avatar

    Roger, I am glad that KSS has a loyal friend, but I find your confusing of character and intellect confounding. A spark...

  • Travis Johnson, Stock Gumshoe

    Dr. KSS is no longer working with Stock Gumshoe, but he is available on Twitter if you want to follow up with him (@KSSM...

  • Avatar

    Hi. Can someone form Gummunity please post Dr KSS’ Monthly conference call number ? Been on here a while but have ne...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch